PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97266413 |
Filing Date: 02/14/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97266413 |
---|---|
MARK INFORMATION | |
*MARK | OMETARX |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | OMETARX |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Astellas Pharma Inc. |
*MAILING ADDRESS | 5-1, Nihonbashi-Honcho 2-Chome, Chuo-Ku |
*CITY | Tokyo |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Japan |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
103-8411 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Japan |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 009 |
*IDENTIFICATION | Computer application software for use with web-based platforms and mobile devices in the nature of tablet computers, PDAs and mobile phones, namely, software for use in accessing a patient's implanted medical device data and transmitting information in the nature of diagnosis of disease including the self-management of symptoms and disabilities, the real-time monitoring of physical and biological indicators, the management of complex medication regimens in order to maintain proper levels of nutrition, diet or exercise which embodies a patient-centric approach for early disease detection whilst aiding and fostering a closer interaction between patients and healthcare providers |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Christian Morgan |
ATTORNEY DOCKET NUMBER | 220055 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Baker & McKenzie LLP |
INTERNAL ADDRESS | Suite 5000 |
STREET | 300 E. Randolph Street |
CITY | Chicago |
STATE | Illinois |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 60601 |
PHONE | 312-861-8233 |
FAX | 312-698-2123 |
EMAIL ADDRESS | chiusptomail@bakermckenzie.com |
OTHER APPOINTED ATTORNEY | David Davis, Shima Roy, Rebecca Lederhouse, and Emily Mola |
DOMESTIC REPRESENTATIVE INFORMATION | |
NAME | Christian Morgan |
FIRM NAME | Baker & McKenzie LLP |
INTERNAL ADDRESS | Suite 5000 |
STREET | 300 E. Randolph Street |
CITY | Chicago |
STATE | Illinois |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP CODE | 60601 |
PHONE | 312-861-8233 |
FAX | 312-698-2123 |
EMAIL ADDRESS | chiusptomail@bakermckenzie.com |
CORRESPONDENCE INFORMATION | |
NAME | Christian Morgan |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | chiusptomail@bakermckenzie.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | christian.morgan@bakermckenzie.com; david.davis@bakermckenzie.com; meri.mclaughlin@bakermckenzie.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
ORIGINAL PDF FILE | hw_104129196147-115019608 _._Astellas_Pharma_Inc_Po A_2022-2-1.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\972\664\97266413\xml1\ APP0003.JPG |
SIGNATORY'S NAME | Yoriko Suzuki |
SIGNATORY'S POSITION | Staff Executive Director, IP Legal |
SIGNATURE METHOD | Handwritten |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97266413 |
Filing Date: 02/14/2022 |
The applicant's current Correspondence Information: |
Christian Morgan |
PRIMARY EMAIL FOR CORRESPONDENCE: chiusptomail@bakermckenzie.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): christian.morgan@bakermckenzie.com; david.davis@bakermckenzie.com; meri.mclaughlin@bakermckenzie.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |